Benjamin L Mazer1, Rachel A Cameron2, Jane M DeLuca3, Supriya G Mohile4, Ronald M Epstein5. 1. Department of Family Medicine, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: Benjamin_Mazer@urmc.rochester.edu. 2. Department of Family Medicine, University of Rochester Medical Center, Rochester, NY, USA. 3. School of Nursing, Clemson University, Clemson, SC, USA. 4. Department of Medicine, James Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA. 5. Departments of Family Medicine, Psychiatry, Oncology, and Nursing, University of Rochester Medical Center, Rochester, NY, USA.
Abstract
OBJECTIVE: To examine using audio-recorded encounters the extent and process of companion participation when discussing treatment choices and prognosis in the context of a life-limiting cancer diagnosis. METHODS: Qualitative analysis of transcribed outpatient visits between 17 oncologists, 49 patients with advanced cancer, and 34 companions. RESULTS: 46 qualifying companion statements were collected from a total of 28 conversations about treatment choices or prognosis. We identified a range of companion positions, from "pseudo-surrogacy" (companion speaking as if the patient were not able to speak for himself), "hearsay", "conflation of thoughts", "co-experiencing", "observation as an outsider", and "facilitation". Statements made by companions were infrequently directly validated by the patient. CONCLUSION: Companions often spoke on behalf of patients during discussions of prognosis and treatment choices, even when the patient was present and capable of speaking on his or her own behalf. PRACTICE IMPLICATIONS: The conversational role of companions as well as whether the physician checks with the patient can determine whether a companion facilitates or inhibits patient autonomy and involvement. Physicians can reduce ambiguity and encourage patient participation by being aware of when and how companions may speak on behalf of patients and by corroborating the companion's statement with the patient.
OBJECTIVE: To examine using audio-recorded encounters the extent and process of companion participation when discussing treatment choices and prognosis in the context of a life-limiting cancer diagnosis. METHODS: Qualitative analysis of transcribed outpatient visits between 17 oncologists, 49 patients with advanced cancer, and 34 companions. RESULTS: 46 qualifying companion statements were collected from a total of 28 conversations about treatment choices or prognosis. We identified a range of companion positions, from "pseudo-surrogacy" (companion speaking as if the patient were not able to speak for himself), "hearsay", "conflation of thoughts", "co-experiencing", "observation as an outsider", and "facilitation". Statements made by companions were infrequently directly validated by the patient. CONCLUSION: Companions often spoke on behalf of patients during discussions of prognosis and treatment choices, even when the patient was present and capable of speaking on his or her own behalf. PRACTICE IMPLICATIONS: The conversational role of companions as well as whether the physician checks with the patient can determine whether a companion facilitates or inhibits patient autonomy and involvement. Physicians can reduce ambiguity and encourage patient participation by being aware of when and how companions may speak on behalf of patients and by corroborating the companion's statement with the patient.
Authors: Cleveland G Shields; Ronald M Epstein; Kevin Fiscella; Peter Franks; Robert McCann; Kevin McCormick; Julie B Mallinger Journal: J Am Board Fam Pract Date: 2005 Sep-Oct
Authors: Dominick L Frosch; Suepattra G May; Katharine A S Rendle; Caroline Tietbohl; Glyn Elwyn Journal: Health Aff (Millwood) Date: 2012-05 Impact factor: 6.301
Authors: Kah Poh Loh; Huiwen Xu; Anthony Back; Paul R Duberstein; Supriya Gupta Mohile; Ronald Epstein; Colin McHugh; Heidi D Klepin; Gregory Abel; Stephanie J Lee; Areej El-Jawahri; Thomas W LeBlanc Journal: Cancer Date: 2019-12-06 Impact factor: 6.921
Authors: Maria Angela Mazzi; Cinzia Perlini; Giuseppe Deledda; Alberto Ghilardi; Chiara Buizza; Alessandro Bottacini; Claudia Goss; Lidia Del Piccolo Journal: BMJ Open Date: 2020-09-29 Impact factor: 2.692